AU2001291962A1 - Angiogenic agents and their uses - Google Patents

Angiogenic agents and their uses

Info

Publication number
AU2001291962A1
AU2001291962A1 AU2001291962A AU9196201A AU2001291962A1 AU 2001291962 A1 AU2001291962 A1 AU 2001291962A1 AU 2001291962 A AU2001291962 A AU 2001291962A AU 9196201 A AU9196201 A AU 9196201A AU 2001291962 A1 AU2001291962 A1 AU 2001291962A1
Authority
AU
Australia
Prior art keywords
angiogenic agents
angiogenic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291962A
Other languages
English (en)
Inventor
Joanna Bakala
Jerome Bignon
Nathalie Cheviron
Yves Fromes
Francoise Lawrence
Pierre Jean-Paul Potier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2001291962A1 publication Critical patent/AU2001291962A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001291962A 2000-09-21 2001-09-20 Angiogenic agents and their uses Abandoned AU2001291962A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012028 2000-09-21
FR0012028A FR2814076B1 (fr) 2000-09-21 2000-09-21 Agent angiogenique et ses utilisations
PCT/FR2001/002923 WO2002024218A1 (fr) 2000-09-21 2001-09-20 Agent angiogeniques et leurs utilisations

Publications (1)

Publication Number Publication Date
AU2001291962A1 true AU2001291962A1 (en) 2002-04-02

Family

ID=8854526

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291962A Abandoned AU2001291962A1 (en) 2000-09-21 2001-09-20 Angiogenic agents and their uses

Country Status (9)

Country Link
US (1) US7235532B2 (fr)
EP (1) EP1318829B1 (fr)
JP (1) JP4925551B2 (fr)
AU (1) AU2001291962A1 (fr)
CA (1) CA2423190C (fr)
DE (1) DE60110247T2 (fr)
ES (1) ES2240520T3 (fr)
FR (1) FR2814076B1 (fr)
WO (1) WO2002024218A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
FR2882256B1 (fr) 2005-02-18 2007-05-25 Centre Nat Rech Scient Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent pour ralentir la chute des cheveux et/ou stimuler leur croissance
KR101335203B1 (ko) 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도
EP2407478A1 (fr) 2010-07-14 2012-01-18 GENETADI Biotech, S.L. Nouveaux cyclotetrapeptides ayant des propriétés pro-angiogenèse
RU2687151C2 (ru) * 2013-06-14 2019-05-07 Хеликс Биомедикс Инк. Тетрапептиды, полученные из с-х-с-хемокинов человека, подходящие для лечения различных состояний кожи

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129121T2 (de) * 1990-12-21 1998-11-19 Curative Tech Inc Angiogene peptide
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen
CA2244673A1 (fr) * 1996-02-01 1997-08-07 Josiane Thierry Peptides inhibiteurs de la proliferation de cellules hematopoietiques
EP2311485A1 (fr) * 1998-07-30 2011-04-20 The Government of the United States of America, as represented by the Secretary of Health and Human Services Thymosine beta 4 pour accélérer la guérison des plaies
US6815426B2 (en) * 2001-02-16 2004-11-09 E. I. Du Pont De Nemours And Company Angiogenesis-inhibitory tripeptides, compositions and their methods of use

Also Published As

Publication number Publication date
DE60110247D1 (de) 2005-05-25
FR2814076B1 (fr) 2002-12-20
DE60110247T2 (de) 2006-03-09
CA2423190C (fr) 2011-06-07
US7235532B2 (en) 2007-06-26
CA2423190A1 (fr) 2002-03-28
WO2002024218A1 (fr) 2002-03-28
JP4925551B2 (ja) 2012-04-25
EP1318829A1 (fr) 2003-06-18
JP2004509148A (ja) 2004-03-25
ES2240520T3 (es) 2005-10-16
FR2814076A1 (fr) 2002-03-22
EP1318829B1 (fr) 2005-04-20
US20040038907A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001290779A1 (en) Shampoo and body wash composition
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU6590500A (en) Vegf-d and angiogenic use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001248817A1 (en) Form panel and panel holding member
AU2001229439A1 (en) Bioconjugates and uses thereof
AU7458201A (en) Laminate and use thereof
AU2001261750A1 (en) Laminate and its use
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001236100A1 (en) Vasoactive agents
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2001262963A1 (en) Laminin 15 and uses thereof
AU2001232332A1 (en) Leptin-resistance ameliorating agents
AU2001291962A1 (en) Angiogenic agents and their uses
AU4432001A (en) Trityl-type compounds and their use